Chernov A, Kilina D, Smirnova T, Galimova E
Pharmaceutics. 2022; 14(11).
PMID: 36432633
PMC: 9693450.
DOI: 10.3390/pharmaceutics14112441.
Guo X, Wang X, Shen S, Oronsky B, Reid T, Stirn M
Am J Cancer Res. 2022; 12(9):4448-4457.
PMID: 36225630
PMC: 9548015.
Maeda A, Ando H, Irie K, Hashimoto N, Morishige J, Fukushima S
Eur J Clin Pharmacol. 2022; 78(8):1239-1247.
PMID: 35527301
DOI: 10.1007/s00228-022-03331-0.
Munisamy M, Munisamy S, Kumar J, Jose A, Thomas L, Baburaj G
Pharmacogenomics J. 2021; 21(2):262-272.
PMID: 33589792
DOI: 10.1038/s41397-021-00206-y.
Wang T, Zhou Y, Cao G
Eur J Clin Pharmacol. 2021; 77(8):1095-1111.
PMID: 33515076
DOI: 10.1007/s00228-021-03088-y.
Combinations of common SNPs of the transporter gene ABCB1 influence apparent bioavailability, but not renal elimination of oral digoxin.
Hsin C, Stoffel M, Gazzaz M, Schaeffeler E, Schwab M, Fuhr U
Sci Rep. 2020; 10(1):12457.
PMID: 32719417
PMC: 7385621.
DOI: 10.1038/s41598-020-69326-y.
P-glycoprotein polymorphism and levothyroxine bioavailability in hypothyroid patients.
Oztas E, Parejo Garcia-Saavedra A, Yanar F, Ozcinar B, Aksakal N, Purisa S
Saudi Pharm J. 2018; 26(2):274-278.
PMID: 30166928
PMC: 6111188.
DOI: 10.1016/j.jsps.2017.11.012.
Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation.
Fu R, Tajima S, Suetsugu K, Watanabe H, Egashira N, Masuda S
Acta Pharmacol Sin. 2018; 40(2):151-159.
PMID: 29950613
PMC: 6329804.
DOI: 10.1038/s41401-018-0070-2.
Effect of MDR1 C1236T polymorphism on cyclosporine pharmacokinetics: A systematic review and meta-analysis.
Chen Z, Zhang L, Yang C, Jiang Z, Shen H, Gui G
Medicine (Baltimore). 2018; 96(47):e8700.
PMID: 29381954
PMC: 5708953.
DOI: 10.1097/MD.0000000000008700.
Population pharmacokinetics of gabapentin in healthy Korean subjects with influence of genetic polymorphisms of ABCB1.
Tran P, Yoo H, Ngo L, Cho H, Lee Y
J Pharmacokinet Pharmacodyn. 2017; 44(6):567-579.
PMID: 29018999
DOI: 10.1007/s10928-017-9549-6.
The effect of MDR1 C3435T polymorphism on the eradication rate of H. pylori infection in PPI-based triple therapy: A meta-analysis.
Li M, Li T, Guo S, Liang H, Jiang D
Medicine (Baltimore). 2017; 96(13):e6489.
PMID: 28353592
PMC: 5380276.
DOI: 10.1097/MD.0000000000006489.
The Usefulness of Determining Neutrophil Gelatinase-Associated Lipocalin Concentration Excreted in the Urine in the Evaluation of Cyclosporine A Nephrotoxicity in Children with Nephrotic Syndrome.
Gacka E, Zyczkowski M, Bogacki R, Paradysz A, Hyla-Klekot L
Dis Markers. 2017; 2016:6872149.
PMID: 28115789
PMC: 5220415.
DOI: 10.1155/2016/6872149.
Effect of MDR1 gene polymorphisms on mortality in paraquat intoxicated patients.
Kim H, Kim H, Kwon J, Lee S, El Park S, Gil H
Sci Rep. 2016; 6:31765.
PMID: 27545861
PMC: 4992846.
DOI: 10.1038/srep31765.
The POR rs1057868-rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients.
Liu S, Chen R, Li J, Zhang Y, Wang X, Fu Q
Acta Pharmacol Sin. 2016; 37(9):1251-8.
PMID: 27498776
PMC: 5022105.
DOI: 10.1038/aps.2016.77.
Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
Wang Y, Li J, Wang X, Zhang Y, Wang C, Huang M
Acta Pharmacol Sin. 2015; 36(7):855-62.
PMID: 25891084
PMC: 4648117.
DOI: 10.1038/aps.2015.6.
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature.
Wolking S, Schaeffeler E, Lerche H, Schwab M, Nies A
Clin Pharmacokinet. 2015; 54(7):709-35.
PMID: 25860377
DOI: 10.1007/s40262-015-0267-1.
Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.
Ji W, Li N, Ju K, Zheng H, Yang C, Xu P
Neurol Sci. 2014; 36(4):561-70.
PMID: 25367405
DOI: 10.1007/s10072-014-1992-1.
Impact of CYP3A4 and MDR1 gene (G2677T) polymorphisms on dose requirement of the cyclosporine in renal transplant Egyptian recipients.
Sharaki O, Zeid M, Moez P, Zakaria N, Nassar E
Mol Biol Rep. 2014; 42(1):105-17.
PMID: 25240575
DOI: 10.1007/s11033-014-3747-8.
Polymorphisms of the vincristine pathway and response to treatment in children with childhood acute lymphoblastic leukemia.
Ceppi F, Langlois-Pelletier C, Gagne V, Rousseau J, Ciolino C, De Lorenzo S
Pharmacogenomics. 2014; 15(8):1105-16.
PMID: 25084203
PMC: 4443746.
DOI: 10.2217/pgs.14.68.
Digging up the human genome: current progress in deciphering adverse drug reactions.
Su S, Chung W, Hung S
Biomed Res Int. 2014; 2014:824343.
PMID: 24734245
PMC: 3966344.
DOI: 10.1155/2014/824343.